DISSECTING THE ROLE OF CANCER CELL CHROMATIN REMODELING ON THE LANDSCAPE OF TUMOR IMMUNE MICROENVIRONMENT
$801,755FY2022Defense Health AgencyDOD
Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell
Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell